Global DNA Vaccine Market Research and Forecast, 2018-2023

INDORE, India - June 23, 2018 - PRLog -- DNA VACCINES MARKET INSIGHTS:
DNA vaccines Market are the third generation vaccines that designed to overcome the undesirable properties of conventional vaccines. The increasing exposure of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity. DNA vaccines have low risk of infection, easy transportation and stability at room temperature and hence are advantageous over traditional vaccines. DNA vaccines target a wide range of traditional pharmaceutical markets, such as cancers and allergies, as well as infectious diseases.

The global DNA vaccines market is experiencing rapid growth owing to the factors such adoption of DNA vaccines in healthcare, low costs of DNA vaccines, and increasing investments in DNA technology. The increase in the prevalence of chronic diseases such as cancer, hepatitis, HIV and others are augmenting the growth of the global DNA vaccine market. Moreover, relative ease of large-scale manufacturing compared to traditional approach and less storage requirement are some of the key market drivers. The other factors augmenting the growth of the market includes increasing clinical trials for DNA vaccines both animal based and human based. Several DNA vaccine clinical trials have been recently completed or are currently ongoing, such as ZYC101 (Eisai Pharmaceuticals) has completed phase I trial. HPV-16 and HPV-18 E6/E7 are being evaluated in a phase I clinical trial (Inovio Pharmaceuticals). DNA vaccines have already made significant progress to date. Nearly 100 clinical trials are on-going in humans for a wide range of diseases, and there is a deep pipeline of preclinical projects.

Report Sample at: https://www.omrglobal.com/industry-reports/dna-vaccines-m...

However, uncertainty in regulatory policies and less penetration of DNA vaccine technology in the emerging economies is hindering the growth of the market. However, the increasing benefits offered by the DNA based vaccines and increasing awareness will have a positive impact on the growth of the market in the future.

The DNA vaccine market is segmented on the basis type, technology and application. On the basis of type, the market is segmented into animal DNA vaccine and human DNA vaccine. On the basis of technology, the market is bifurcated into Plasmid DNA vaccine and plasmid DNA delivery technology. On the basis of application, the market is divided into oncology, infectious diseases and others.

The companies contributing to the growth of global DNA vaccine market are Astellas Pharma, Bharat Biotech, Dendreon Corporation, Indian Immunologicals Limited, GE Healthcare Life Sciences, GlaxoSmithKline Inc., Green Cross Corporation, Innovio Biomedical Corporation, Pfizer Pharmaceuticals, Sanofi, The Serum Institute of India Pvt. Limited, Zoetis Inc. and so on. US – AgriLabs in November 2017, announced the United States Department of Agriculture (USDA) approval of the first DNA vaccine licensed for chickens. The approval also represents the first for AgriLabs ExactVacTM DNA technology with ENABL adjuvant, the first DNA vaccine approved for influenza for veterinary use, and among the first DNA vaccines approved in the US  for food animals.

• Global DNA vaccines market by type
• Global DNA vaccines market by technology
• Global DNA vaccines market by application

Research Methodology

The market study of DNA vaccine market is incorporated by extensive primary and secondary research conducted by research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

• Financial reports of companies involved in the market
• Authentic Public Databases
• Whitepapers, research-papers and news blogs
• Company websites and their product catalogue.
• Supplier Websites such as Alibaba, amazon for pricing analysis.

The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

THE REPORT COVERS:
• Comprehensive research methodology of Global DNA Vaccine Market.
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Global DNA Vaccine Market.
• Insights about market determinants which are stimulating the Global DNA Vaccine Market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

For Related Report: https://www.omrglobal.com/reports-category/pharmaceuticals/